Skip To Main Content
Simona Barbato on Muck Rack

Simona Barbato

As seen in: Wiley Online Library, MDPI, Taylor & Francis Online
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Simona

Contact Simona, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma

|
By Katia Mancuso, Simona Barbato, Francesco Di Raimondo, Francesca Gay
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

New Challenges in Bladder Cancer Diagnosis: How Biosensing Tools Can Lead to Population Screening Opportunities

|
By Fabiana Tortora, Simona Barbato, Ferdinando Febbraio, Antonella Guastaferro
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myeloma

|
By Katia Mancuso, Simona Barbato, Marco Talarico, Paola Tacchetti
| Taylor & Francis Online
ABSTRACT Introduction Modern anti-myeloma therapies have broken new ground in the treatment of the disease, and the incorporation of ide-cel in the treatment landscape represents one of the major scientific and clinical advances.
Open in Who Shared Issue with article?
See all 6 articles